Comparing Tai Chi Chih and Relaxation Therapy in the Treatment of Rheumatoid Arthritis
NCT00096759 is a phase 2/3 interventional trial sponsored by National Center for Complementary and Integrative Health (NCCIH). As of 21 Nov 2026, it is completed. It studies Arthritis, Rheumatoid. The registry lists an enrollment of 100 participants at 2 sites in 1 country. The registry lists a start date of 30 Nov 2004 and a primary completion date of 31 Aug 2007.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00096759 |
| Status | Completed |
| Phase | Phase 2/3 |
| Study type | Interventional trial |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH) |
| Enrollment | 100 |
| Registered sites | 2 |
| Countries | 1 |
| Conditions | Arthritis, Rheumatoid |
| Start | 30 Nov 2004 |
| Primary completion | 31 Aug 2007 |
| Study completion | 31 Aug 2007 |
| Last update posted | 22 Mar 2013 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Jennifer Pike, PhD
University of California, Los Angeles
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sinai Medical Center
Los Angeles
- University of California, Los Angeles Medical Center
Los Angeles
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT00096759
Each answer restates registry values shown on this page.
What is NCT00096759?
NCT00096759 is a phase 2/3 interventional trial sponsored by National Center for Complementary and Integrative Health (NCCIH). It studies Arthritis, Rheumatoid.
Who leads NCT00096759?
The registry names Jennifer Pike, PhD (principal investigator, University of California, Los Angeles) as the overall official.
Where does NCT00096759 run?
The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.
When did NCT00096759 end?
The registry lists a primary completion date of 31 Aug 2007 and a study completion date of 31 Aug 2007. The sponsor last updated the record on 22 Mar 2013.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.